Selank
Tuftsin-analog anxiety-easing research peptide — not FDA-approved.
What it's for
Selank is a synthetic analog of the immunomodulatory peptide tuftsin, studied primarily in Russian research for anxiety and stress-related endpoints.
What it does for the body
It has been investigated for anxiety-easing-like and cognitive effects. It is not FDA-approved as an anxiety medicine. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Research suggests effects on calming brain-signal (GABA) and mood-related brain chemicals systems and on expression of certain neurotrophic/immune genes; how it works is still framed as multi-pathway gentle adjustment.
Research context
Bottom line for readers: Selank is best treated as a research-interest topic. Early papers can be fascinating; they are not a green light for self-experimentation.
Studied for (literature interest)
- Brain research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Selank — FDA.gov search
- ClinicalTrials.gov search: Selank — U.S. clinical trials registry
- Drugs@FDA search: Selank — FDA drug database (if approved)
- PubMed search: Selank — NCBI PubMed
- PubMed Central search: Selank — NCBI PMC
Reference
No ref on file.